Breaking News, Collaborations & Alliances

Almac Discovery, Elasmogen and Innovate UK Collaborate to Develop Oncology Platform

£2M joint program receives grant to support research into next generation technology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac Discovery, a biopharmaceutical company focused on discovering and identifying therapeutics for the treatment of cancer and Elasmogen, an SME focused on the development of next generation biologics, have been awarded a grant from Innovate UK through its Innovation in Health and Life Sciences funding program. The £2 million peer reviewed collaborative project entitled, “A Technology Platform for Next Generation VNAR based Oncology Medicines,” plans to utilize the highly select...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters